These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 20553282)

  • 61. Very late stent thrombosis after drug-eluting stent in segment with neointimal tissue coverage.
    Nishiguchi T; Kitabata H; Tanaka A; Kataiwa H; Ishibashi K; Komukai K; Tanimoto T; Ino Y; Takarada S; Kubo T; Nakamura N; Mizukoshi M; Imanishi T; Akasaka T
    JACC Cardiovasc Imaging; 2010 Apr; 3(4):445-6. PubMed ID: 20394907
    [No Abstract]   [Full Text] [Related]  

  • 62. Contemporary approaches to perioperative management of coronary stents and to preoperative coronary revascularization: a survey of 374 interventional cardiologists.
    Khair T; Garcia B; Banerjee S; Brilakis ES
    Cardiovasc Revasc Med; 2011; 12(2):99-104. PubMed ID: 21421188
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Stent thrombosis in Sweden: a report from the Swedish Coronary Angiography and Angioplasty Registry.
    Lagerqvist B; Carlsson J; Fröbert O; Lindbäck J; Scherstén F; Stenestrand U; James SK;
    Circ Cardiovasc Interv; 2009 Oct; 2(5):401-8. PubMed ID: 20031749
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Antiplatelet therapy following drug-eluting stent implantation: new clinical data and recommendations.
    Paradis JM; Ducrocq G; Tanguay JF
    Minerva Cardioangiol; 2008 Feb; 56(1):139-54. PubMed ID: 18432176
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Drug-eluting stents for ST-segment elevation myocardial infarction: treatment of choice or is discretion the better part of valor?
    Rihal CS
    JACC Cardiovasc Interv; 2008 Jun; 1(3):233-5. PubMed ID: 19463305
    [No Abstract]   [Full Text] [Related]  

  • 66. Intravascular ultrasound optimization of drug-eluting stents: still not enough data.
    Leesar MA
    Catheter Cardiovasc Interv; 2010 Mar; 75(4):584-5. PubMed ID: 20333656
    [No Abstract]   [Full Text] [Related]  

  • 67. Provisional side branch stenting for the treatment of bifurcation lesions.
    Lefèvre T; Darremont O; Albiero R
    EuroIntervention; 2010 Dec; 6 Suppl J():J65-71. PubMed ID: 21930493
    [No Abstract]   [Full Text] [Related]  

  • 68. Coronary stents: historical development, current status and future directions.
    Iqbal J; Gunn J; Serruys PW
    Br Med Bull; 2013; 106():193-211. PubMed ID: 23532779
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Each generation improves on the last (in cardiology): Bayesian thinking, the randomized clinical trial, and directed evolution.
    Morrison DA
    Catheter Cardiovasc Interv; 2011 Jun; 77(7):1018-9. PubMed ID: 21598353
    [No Abstract]   [Full Text] [Related]  

  • 70. Stent thrombosis: an overview.
    Centemero MP; Stadler JR
    Expert Rev Cardiovasc Ther; 2012 May; 10(5):599-615. PubMed ID: 22651836
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Stent expansion as a mechanical parameter to predict late stent patency: back to the basics.
    Honda Y; Fitzgerald PJ
    JACC Cardiovasc Interv; 2009 Dec; 2(12):1276-8. PubMed ID: 20129556
    [No Abstract]   [Full Text] [Related]  

  • 72. Duration of dual antiplatelet therapy following percutaneous coronary intervention with drug-eluting stents: a review of recent evidence.
    Acharjee S; Cannon CP
    Crit Pathw Cardiol; 2010 Dec; 9(4):203-6. PubMed ID: 21119338
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Late or very late stent thrombosis can also occur with bare metal stents.
    Ramos AR; Morice MC; Lefèvre T
    Catheter Cardiovasc Interv; 2007 Aug; 70(2):229-32. PubMed ID: 17632773
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [The bioresorbable coronary scaffold].
    Hassell ME; van de Hoef TP; Damman P; Delewi R; Serruys PW; Piek JJ
    Ned Tijdschr Geneeskd; 2012; 156(36):A4994. PubMed ID: 22951133
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Drug-eluting stent thrombosis: the Kounis hypersensitivity-associated acute coronary syndrome revisited.
    Chen JP; Hou D; Pendyala L; Goudevenos JA; Kounis NG
    JACC Cardiovasc Interv; 2009 Jul; 2(7):583-93. PubMed ID: 19628178
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Stent thrombosis.
    Holmes DR; Kereiakes DJ; Garg S; Serruys PW; Dehmer GJ; Ellis SG; Williams DO; Kimura T; Moliterno DJ
    J Am Coll Cardiol; 2010 Oct; 56(17):1357-65. PubMed ID: 20946992
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Rotational atherectomy with drug-eluting stents: a necessary technique in the current era.
    Lozano I; Rondan J; Avanzas P
    Catheter Cardiovasc Interv; 2011 Jan; 77(1):160; author reply 161. PubMed ID: 21069801
    [No Abstract]   [Full Text] [Related]  

  • 78. Innovations in drug-eluting stents.
    Nallu K; Yang DC; Swaminathan RV; Kim LK; Feldman D
    Panminerva Med; 2013 Dec; 55(4):345-52. PubMed ID: 24434343
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Current percutaneous coronary intervention technology for management of coronary artery disease].
    Miyazawa A; Kozuma K
    Nihon Rinsho; 2011 Feb; 69(2):224-9. PubMed ID: 21387667
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The fork in the road: a dedicated turn or a provisional one?
    Mehran R
    Catheter Cardiovasc Interv; 2011 May; 77(6):807-8. PubMed ID: 21520382
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.